← Open Payments lookup

RALPH BURROUGHS: Open Payments

NPI 1760674949 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$573 in 24 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $393 · 2025 $573

Food & beverage: $573
CompanyPaymentsAmount
ABBVIE INC.10$170
E.R. Squibb & Sons, L.L.C.5$115
Axsome Therapeutics, Inc.1$95
Alkermes, Inc.2$52
Otsuka America Pharmaceutical, Inc.2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Teva Pharmaceuticals USA, Inc.1$27
Lundbeck LLC1$24

Products named: VRAYLAR, COBENFY, Auvelity, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across MS — which companies pay providers there.